Liat Orenstein
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Liat Orenstein has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Rachel Dankner
School of Public Health, Grey Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel
7 shared publications Keren Laufer
Pharmaceutics Registration Department Teva Israel Ltd. Shoham Israel
5 shared publicationsAngela Chetrit
Public Health Research Center Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center Ramat‐Gan Israel
4 shared publications- Angela Chetrit
Public Health Research Center Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center Ramat‐Gan Israel
4 shared publications - Sharon Stein Merkin
Gertner Institute of Epidemiology and Health Policy, Sheba Medical Center
3 shared publications - Adam G. Dunn
Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia
2 shared publications
Latest Publications
- Open Access
- 10 August 2026
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
Volunteering and resilience in wartime: evidence from two population-based studies in Israel
Background: Resilience is a key factor in coping with and recovering from large-scale traumatic events. Although volunteering has generally been associated with improving or maintaining resilience, evidence from wartime contexts is mixed. This study examined the association between volunteering during armed conflict and individual resilience. Methods: We used data from two population-based studies, conducted within six weeks (Study 1, n = 453) and 6 months after (Study 2, n = 1035) the October 7th, 2023 terror attacks and onset of the ensuing war in Israel. In Study 1, multivariable linear regression models were utilized to assess the association between psychological exposure to war and resilience, while accounting for potential interaction between psychological exposure to war and volunteering. In Study 2, latent class analysis was used to identify patterns of volunteering based on type, duration and frequency of activities. Multivariable linear regression models then examined associations between volunteering patterns and resilience, followed by a mediation analysis assessing the role of social integration. Results: A statistically significant interaction emerged in Study 1 indicating that the relationship between psychological war exposure and resilience was weaker when volunteering was higher. Study 2 found that the pattern characterized by high intensity volunteering at logistic distribution centers was significantly associated with higher resilience ( β = 0.49, p = 0.001), with social integration mediating 31% of this effect. Conclusion: These findings show a persistent association between substantive communal volunteering and higher resilience that may buffer the negative impact of war exposure.
- 10 August 2026
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
Open AccessVolunteering and resilience in wartime: evidence from two population-based studies in Israel
Background: Resilience is a key factor in coping with and recovering from large-scale traumatic events. Although volunteering has generally been associated with improving or maintaining resilience, evidence from wartime contexts is mixed. This study examined the association between volunteering during armed conflict and individual resilience. Methods: We used data from two population-based studies, conducted within six weeks (Study 1, n = 453) and 6 months after (Study 2, n = 1035) the October 7th, 2023 terror attacks and onset of the ensuing war in Israel. In Study 1, multivariable linear regression models were utilized to assess the association between psychological exposure to war and resilience, while accounting for potential interaction between psychological exposure to war and volunteering. In Study 2, latent class analysis was used to identify patterns of volunteering based on type, duration and frequency of activities. Multivariable linear regression models then examined associations between volunteering patterns and resilience, followed by a mediation analysis assessing the role of social integration. Results: A statistically significant interaction emerged in Study 1 indicating that the relationship between psychological war exposure and resilience was weaker when volunteering was higher. Study 2 found that the pattern characterized by high intensity volunteering at logistic distribution centers was significantly associated with higher resilience ( β = 0.49, p = 0.001), with social integration mediating 31% of this effect. Conclusion: These findings show a persistent association between substantive communal volunteering and higher resilience that may buffer the negative impact of war exposure.
- Open Access
- 17 January 2026
- Published by Elsevier in Comprehensive Psychiatry
- Vol. 146, 152665
Overall and sex-specific associations between secondary trauma exposure and health decline post October 7th, 2023: a population-based study
- 17 January 2026
- Published by Elsevier in Comprehensive Psychiatry
- Vol. 146, 152665
Open AccessOverall and sex-specific associations between secondary trauma exposure and health decline post October 7th, 2023: a population-based study
- 13 January 2026
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 74 (4) , 1205-1206
Reply to “From Evidence to Impact: Bridging the Implementation Gap in Geriatric Deprescribing”
- 13 January 2026
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 74 (4) , 1205-1206
Reply to “From Evidence to Impact: Bridging the Implementation Gap in Geriatric Deprescribing”
- 8 November 2025
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 74 (2) , 605-606
Reply to: Inappropriate Prescribing and Medication Safety in Older Adults
- 8 November 2025
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 74 (2) , 605-606
Reply to: Inappropriate Prescribing and Medication Safety in Older Adults
- Open Access
- 11 September 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (9) , e0332210
Associations of high-risk drug patterns with mortality among community-dwelling older adults: A 23-year prospective cohort study
Background: Data on drug safety in multimorbid older-adults are limited, as clinical trials often apply upper age limits and focus on individual drugs or specific combinations. We aimed to explore high-risk drug patterns in community-dwelling older-adults, and their associations with long-term mortality. Methods: We included 1,048 participants from a longitudinal population-based cohort, all taking at least one medication. Participants were examined in 1999–2007 and followed for mortality through March 2022. Individuals with similar profiles of high-risk drugs, identified using Beers criteria as potentially inappropriate for most older adults or requiring caution, were grouped using agglomerative hierarchical clustering. Cox and competing-risk regressions were used to examine the associations of the high-risk drug patterns with all-cause and non-cancer mortality. Results: The most prevalent morbidities among participants (mean age 73.3 ± 7.3 years, 55.9% women) were hypertension (55.3%) and cardiovascular diseases (45.5%), and 77.7% took at least one high-risk drug. Five distinct patterns were identified: ‘None’ cluster (no dominant high-risk drug); ‘Calcium channel blockers’ (CCBs) cluster, with high nonsteroidal anti-inflammatory drug (NSAID) prevalence; ‘Renin-angiotensin-aldosterone system (RAAS) inhibitors’ cluster, with a high concomitant use of sulfonylureas compared to other clusters; ’Diuretics’ cluster, with a relatively high prevalence of antithrombotics and proton pump inhibitors; and ’Benzodiazepines’ cluster, with a relatively high antidepressant prevalence. Clusters differed by age, sex, ethnicity, and health characteristics. In multivariable analysis, the ‘Diuretics’ cluster was associated with increased all-cause (HR = 1.33, 95%CI: 1.03–1.72) and non-cancer (HR = 1.41, 95%CI: 1.03–1.93) mortality compared to the ‘None’ cluster. The ‘CCBs’ cluster was associated with a greater risk for non-cancer mortality. Several drug combinations were identified as potential contributors to the increased risk observed in these clusters, including the concomitant use of NSAIDs and antihypertensives and a possible CCB-diuretic prescribing cascade. Conclusions: Examining high-risk drug patterns offers a patient-centered approach to improving evidence-based medication guidelines and facilitating early interventions for vulnerable older-adults.
- 11 September 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (9) , e0332210
Open AccessAssociations of high-risk drug patterns with mortality among community-dwelling older adults: A 23-year prospective cohort study
Background: Data on drug safety in multimorbid older-adults are limited, as clinical trials often apply upper age limits and focus on individual drugs or specific combinations. We aimed to explore high-risk drug patterns in community-dwelling older-adults, and their associations with long-term mortality. Methods: We included 1,048 participants from a longitudinal population-based cohort, all taking at least one medication. Participants were examined in 1999–2007 and followed for mortality through March 2022. Individuals with similar profiles of high-risk drugs, identified using Beers criteria as potentially inappropriate for most older adults or requiring caution, were grouped using agglomerative hierarchical clustering. Cox and competing-risk regressions were used to examine the associations of the high-risk drug patterns with all-cause and non-cancer mortality. Results: The most prevalent morbidities among participants (mean age 73.3 ± 7.3 years, 55.9% women) were hypertension (55.3%) and cardiovascular diseases (45.5%), and 77.7% took at least one high-risk drug. Five distinct patterns were identified: ‘None’ cluster (no dominant high-risk drug); ‘Calcium channel blockers’ (CCBs) cluster, with high nonsteroidal anti-inflammatory drug (NSAID) prevalence; ‘Renin-angiotensin-aldosterone system (RAAS) inhibitors’ cluster, with a high concomitant use of sulfonylureas compared to other clusters; ’Diuretics’ cluster, with a relatively high prevalence of antithrombotics and proton pump inhibitors; and ’Benzodiazepines’ cluster, with a relatively high antidepressant prevalence. Clusters differed by age, sex, ethnicity, and health characteristics. In multivariable analysis, the ‘Diuretics’ cluster was associated with increased all-cause (HR = 1.33, 95%CI: 1.03–1.72) and non-cancer (HR = 1.41, 95%CI: 1.03–1.93) mortality compared to the ‘None’ cluster. The ‘CCBs’ cluster was associated with a greater risk for non-cancer mortality. Several drug combinations were identified as potential contributors to the increased risk observed in these clusters, including the concomitant use of NSAIDs and antihypertensives and a possible CCB-diuretic prescribing cascade. Conclusions: Examining high-risk drug patterns offers a patient-centered approach to improving evidence-based medication guidelines and facilitating early interventions for vulnerable older-adults.
- Open Access
- 11 August 2025
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 73 (9) , 2828-2838
A Prospective Study on Potentially Inappropriate Drug Use and All‐Cause Mortality in Community‐Dwelling Older Adults
Background: Potentially inappropriate prescribing (PIP), encompassing potentially inappropriate medications (PIMs) and prescribing omissions (PPOs), is prevalent among older adults and consistently associated with adverse health outcomes. However, evidence on its impact on mortality remains limited. We examined the associations of PIMs and PPOs with long‐term mortality in a cohort of community‐dwelling older adults.Methods: One thousand two hundred and ten participants from the third follow‐up (1999–2007) of a longitudinal prospective cohort study were followed for mortality until 03/2022. PIMs and PPOs were identified using the 2023 Beers and the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions/Screening Tool to Alert doctors to Right Treatment (STOPP/START) v3 criteria. Cox proportional hazards and Fine–Gray subdistribution hazard models assessed associations between PIP and all‐cause and non‐cancer mortality, respectively, adjusting for sociodemographic, lifestyle, and health‐related factors.Results: Overall, 81.2% of participants were exposed to > 1 problem: 52.6% and 45.0% to PIMs based on Beers and STOPP criteria, respectively, and 59.3% to PPOs. In multivariable analysis, exposure to ≥ 2 PIMs was associated with increased all‐cause mortality for Beers (HR = 1.31, 95% CI: 1.04–1.69) and STOPP (HR = 1.25, 95% CI: 1.00–1.55) criteria. An interaction between PIMs (Beers criteria) and self‐rated health (SRH) indicated stronger associations for those with “excellent/good” baseline SRH, compared to those with “poor/very poor” SRH (p‐for‐interaction = 0.030). Use of ≥ 2 PIMs was also associated with a 1.4‐fold increased non‐cancer mortality risk for both tools. Exposure to ≥ 2 PPOs was associated with a 1.8‐fold increase in all‐cause mortality risk (HR = 1.84, 95% CI: 1.24–2.72), while associations were stronger in men (p‐for‐interaction = 0.012). Exposure to 1 or ≥ 2 PPOs was also associated with 1.3 and 2.0‐fold increased non‐cancer mortality risk, respectively.Conclusions: PIP is prevalent and is associated with increased long‐term mortality among community‐dwelling older adults. Addressing PIMs in healthier older individuals and reducing PPOs in clinical practice is critical. Sex‐specific pharmaceutical guidelines are warranted.
- 11 August 2025
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 73 (9) , 2828-2838
Open AccessA Prospective Study on Potentially Inappropriate Drug Use and All‐Cause Mortality in Community‐Dwelling Older Adults
Background: Potentially inappropriate prescribing (PIP), encompassing potentially inappropriate medications (PIMs) and prescribing omissions (PPOs), is prevalent among older adults and consistently associated with adverse health outcomes. However, evidence on its impact on mortality remains limited. We examined the associations of PIMs and PPOs with long‐term mortality in a cohort of community‐dwelling older adults.Methods: One thousand two hundred and ten participants from the third follow‐up (1999–2007) of a longitudinal prospective cohort study were followed for mortality until 03/2022. PIMs and PPOs were identified using the 2023 Beers and the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions/Screening Tool to Alert doctors to Right Treatment (STOPP/START) v3 criteria. Cox proportional hazards and Fine–Gray subdistribution hazard models assessed associations between PIP and all‐cause and non‐cancer mortality, respectively, adjusting for sociodemographic, lifestyle, and health‐related factors.Results: Overall, 81.2% of participants were exposed to > 1 problem: 52.6% and 45.0% to PIMs based on Beers and STOPP criteria, respectively, and 59.3% to PPOs. In multivariable analysis, exposure to ≥ 2 PIMs was associated with increased all‐cause mortality for Beers (HR = 1.31, 95% CI: 1.04–1.69) and STOPP (HR = 1.25, 95% CI: 1.00–1.55) criteria. An interaction between PIMs (Beers criteria) and self‐rated health (SRH) indicated stronger associations for those with “excellent/good” baseline SRH, compared to those with “poor/very poor” SRH (p‐for‐interaction = 0.030). Use of ≥ 2 PIMs was also associated with a 1.4‐fold increased non‐cancer mortality risk for both tools. Exposure to ≥ 2 PPOs was associated with a 1.8‐fold increase in all‐cause mortality risk (HR = 1.84, 95% CI: 1.24–2.72), while associations were stronger in men (p‐for‐interaction = 0.012). Exposure to 1 or ≥ 2 PPOs was also associated with 1.3 and 2.0‐fold increased non‐cancer mortality risk, respectively.Conclusions: PIP is prevalent and is associated with increased long‐term mortality among community‐dwelling older adults. Addressing PIMs in healthier older individuals and reducing PPOs in clinical practice is critical. Sex‐specific pharmaceutical guidelines are warranted.
- Open Access
- 7 March 2024
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 99 (5) , 766-779
Emulated Trial for Discharge Prescription of Guideline-Directed Medical Therapy and 15-Year Survival After Coronary Artery Bypass Graft Surgery
- 7 March 2024
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 99 (5) , 766-779
Open AccessEmulated Trial for Discharge Prescription of Guideline-Directed Medical Therapy and 15-Year Survival After Coronary Artery Bypass Graft Surgery
- 13 November 2023
- Published by Elsevier in Addictive Behaviors
- Vol. 149, 107912
Factors associated with attempting and succeeding in smoking cessation following a National Tobacco Control Plan: Analysis of two nationwide surveys (2010 and 2017)
- 13 November 2023
- Published by Elsevier in Addictive Behaviors
- Vol. 149, 107912
Factors associated with attempting and succeeding in smoking cessation following a National Tobacco Control Plan: Analysis of two nationwide surveys (2010 and 2017)